BridgeBio Pharma, Inc. Announces Proposed Offering of $400 Million Convertible Senior Notes

Go back to BridgeBio Pharma, Inc. Announces Proposed Offering of $400 Million Convertible Senior Notes
(NASDAQ: BBIO) Delayed: 48.03 -1.56 (3.15%)
Previous Close $49.59    52 Week High
Open $49.21    52 Week Low
Day High $50.65    P/E N/A 
Day Low $47.64    EPS
Volume 729,243